SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacia & Upjohn (PNU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stuart Scolnik who wrote (31)4/23/1998 3:06:00 PM
From: esterina   of 43
 
off topic.

RESEARCH ALERT - Vivus raised

Reuters Story - April 23, 1998 13:48

%US %RES %HOT %DRU VVUS PFE V%REUTER P%RTR

Copyright 1998 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters.
Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Jump to first matched term
LOS ANGELES, April 23 (Reuters) - Cruttenden Roth Thursday
raised its rating on Vivus Inc to strong buy from
neutral and set a 1998 price target on the stock of $23 a
share.
--said believes Pfizer Inc's anti-impotence drug
Viagra has safety and efficacy issues which will limit the
patient base the product can treat.
--said Vivus will be well positioned to take advantage of
erectile dysfunction patients who Viagra may not be able to
treat successfully.
--estimated that Viagra may only be effective in 50 percent
of erectile dysfunction patients and that those you find it
ineffective may turn to Vivus' MUSE treatment for impotence.
--said Vivus' new production facility, expected to come
online in mid-1998, will allow it to reap rewards from Pfizer's
marketing campaign which will likely increase the number of men
seeking drugs for erectile dysfunction.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News